How to expedite clinical development of oncology agents: overcoming complexities of early-phase oncology trials for ATMPs

“Drug developers must develop ATMPs in a time- and resource-efficient manner to maximize their assets’ potential. A close understanding of clinical development trends and regulatory opinions is central to this process…”

Please enter your email to access content Read now